Endocrine disorders with chronic renal insufficiency

Padiatrische Praxis

Volumn 61, Issue 3, 2002, Pages 435-446

  Dotsch J ^a   Plank, C ^a   Bosch, B ^a   Dorr H G ^a   Rascher, W ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Delayed puberty; Renal anemia; Renal growth failure; Renal osteodystrophy

Indexed keywords

CALCIUM CHANNEL STIMULATING AGENT; ERYTHROPOIETIN; GROWTH HORMONE; HUMAN GROWTH HORMONE; THYROID HORMONE;

ANEMIA; ARTICLE; BONE METABOLISM; CHRONIC KIDNEY FAILURE; DISEASE ASSOCIATION; ENDOCRINE DISEASE; GROWTH HORMONE DEFICIENCY; GROWTH RETARDATION; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; HYPOGONADOTROPIC HYPOGONADISM; HYPOTHYROIDISM; KIDNEY TRANSPLANTATION; MEDICAL DECISION MAKING; MOLECULAR CLONING; MOLECULAR GENETICS; PUBERTY; SECONDARY HYPERPARATHYROIDISM; UREMIA;

EID: 0036299411     PISSN: 00309346     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. The effects of chronic renal failure in infancy on growth, nutritional status and body composition
2. Spontaneous dietary protein intake during progression of chronic renal failure
3. Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children
4. Congenital renal salt-losing syndrome and failure to thrive in infancy
5. Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism
6. Growth hormone and insulin-like growth factor in non-uremic acidosis and uremic acidosis
7. Metabolic acidosis inhibits growth hormone secretion in rats: Mechanism of growth retardation
8. Effect of metabolic acidosis on the expression of insulin-like growth factor and growth hormone receptor
9. Simultaneous turnover studies of thyroxine, 3,5,3′- and 3,3′,5′-triiodothyronine, 3,5-, 3,3′, and 3′,5′- diiodothyronine, and 3′- monoiodothyronine in chronic renal failure
10. Serum insulin-like growth factors (IGFs) and IGF binding proteins 1, 2, and 3 in children with chronic renal failure: Relationship to height and glomerular filtration rate
11. Growth rates in pediatric dialysis patients and renal transplant recipients
12. Factors predictive of sustained growth in children after renal transplantation. The North American Pediatric Renal Transplant Cooperative Study
13. Effect of growth hormone treatment on the adult height of children with chronic renal failure
14. Stauungspapille im Kindesalter: Pathophysiologie, Differentialdiagnose und Fehlerquellen
15. Metabolic consequences of growth hormone treatment in paediatric practice
16. Nutrition and growth in relation to severity of renal disease in children
17. Puberty in chronic renal failure
18. Androgen therapy in chronic renal failure
19. Pubertal growth in chronic renal failure
20. Immortalization of hypothalamic GnRH neurons by genetically targeted tumorigenesis
21. Immunoreactive and bioactive luteinizing hormone in pubertal patients with chronic renal failure
22. Endocrine abnormalities in patients undergoing long-term hemodialysis. The role of prolactin
23. Prolactinoma causing secondary amenorrhea in a woman with Ullrich-Turner syndrome
24. Pubertal development in Swiss girls
25. Pubertal development in Swiss boys
26. The effects of anabolic steroids on growth, body composition and metabolism in boys with chronic renal failure on regular hemodialysis
27. Growth in four patients on combined treatment with LHRH analogue and growth hormone after renal transplantation
28. Chronic renal failure: Osteodystrophy
29. Bone histology in incipient and advanced renal failure
30. Molecular mechanisms of secondary hyperparathyroidism
31. Phosphorus restriction reverses hyperparathyroidism in uremia independent of changes in calcium and calcitriol
32. Identification of 1,25-dihydroxy-cholecalciferol, a new kidney hormone controlling calcium metabolism
33. Calcium metabolism in early chronic renal failure: Implications for the pathogenesis of hyper-parathyroidism
34. Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue
35. +)-sensing receptor from bovine parathyroid
36. +-sensing receptor: Central mediator of systemic calcium homeostasis
37. Calcimimetics with potent and selective activity on the parathyroid calcium receptor
38. Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis
39. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy
40. Non-aluminic adynamic bone disease in non-dialyzed uremic patients: A new type of osteopathy due to overtreatment?
41. Renal osteodystrophy in children on maintenance haemodialysis
42. Comparison of parathyroid hormone assays with bone histomorphometry in renal osteodystrophy
43. Effects of dietary protein and phosphorus restriction on the progression of early renal failure
44. The treatment of uraemic hyperphosphataemia with calcium acetate and calcium carbonate: A comparative study
45. Long-term effects of calcium carbonate and 2.5mEq/liter calcium dialysate on mineral metabolism
46. RenaGel, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone
47. 3 administration in moderate renal failure: A prospective double-blind trial
48. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis
49. Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD
50. 3 in man
51. NPS R-568 halts or reverses osteitis fibrosa in uremic rats
52. A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism
53. Erythropoietein: Sites of synthesis and regulation of secretion
54. Relation of serum erythropoietin levels to renal excretory function: Evidence for lowered set point for erythropoietin production in chronic renal failure
55. Chronic renal failure: Physiology and Management
56. Erythropoietin treatment in children with renal failure
57. Recombinant human erythropoietin therapy in children on dialysis
58. Assessing iron status in children with chronic renal failure on erythropoietin: Which measurements should we use?